ATRX and central nervous system cancer: To assess whether GNA13 might facilitate similar processes in ATRX-deficient human disease, we examined TCGA gene expression data for lower-grade glioma (LGG), focusing our analysis on those tumors harboring an IDH1 or IDH2 mutation.